远程医疗在肺癌中的应用及前景

doi:10.11904/j.issn.1002-3070.2018.06.014

Abstract

Abstract: Lung cancer is the most malignant tumor with high morbidity and mortality.It is also a global public health problem.China still has insufficient medical treatment and management of lung cancer.Telemedicine is different from the traditional medical model.It can use modern equipment and technology to collect, store, transmit, process and analyze the medical information.It uses a reasonable standard to screen lung cancer patients from high-risk groups, and then collaborates with experts to make diagnosis and treatment.It is helpful for the early diagnosis, precising treatment, comprehensive management of lung cancer, and facilitate the diagnosis and treatment process, health management of primary hospitals and individuals.This article reviews the applications and development prospects of telemedicine in diagnosis, grading diagnosis, mobile medical services, health management and follow-up of lung cancer.

Key words: Lung cancer, Epidemiology, Telemedicine

CLC Number:

R734.2

MULALI Dina, HU Xin, TUOHAYI Jiazina. The application and prospect of telemedicine in lung cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 555-557.

References

1 Torre LA, Bray F, Siegel RL, et al.Global cancer statistics 2012[J].CA Cancer J Clin, 2015, 65(2):87-108.
2 GBD 2015 Risk Factors Collaborators.Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015:a systematic analysis for the Global Burden of Disease Study 2015[J].Lancet, 2016, 388(10053):1659-1724.
3 Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66(2):115-132.
4 Wang Z, Feng F, Zhou X, et al.Development of diagnostic model of lung cancer based on multiple tumor markers and data mining[J].Oncotarget, 2017, 8(55):94793-94804.
5 Siegel RL, Miller KD, Jemal A, et al.Cancer statistics, 2018[J].CA Cancer J Clin, 2018, 68(1):7-30.
6 中国物联网辅助肺结节诊治专家组.物联网辅助肺结节诊治中国专家共识[J].国际呼吸杂志, 2017, 37(8):561-568.
7 白春学.物联网医学三加二式肺结节鉴别诊断法[J].国际呼吸杂志, 2014, 34(16):1201-1202.
8 白春学.五步法物联网医学——分级诊疗的技术平台[J].国际呼吸杂志, 2015, 35(8):561-562.
9 Macpherson CF, Linder LA, Ameringer S, et al.Feasibility and acceptability of an iPad application to explore symptom clusters in adolescents and young adults with cancer[J].Pediatr Blood Cancer, 2014, 61(11):1996-2003.
10 Ye X, Wei J, Li Z, et al.Design and implementation of a mobile system for lung cancer patient follow-up in China and initial report of ongoing patient registry[J].Oncotarget, 2017, 8(3):5487-5497.
11 Ni HJ, Pudasaini B, Yuan XT, et al.Exercise training for patients pre-and postsurgically treated for non-small cell lung cancer:asystematic review and meta-analysis[J].Integr Cancer Ther, 2017, 16(1):63-73.
12 Rueda JR, Sola I, Pascual A, et al.Non-invasive interventions for improving well-being and quality of life in patients with lung cancer[J].Cochrane Database Syst Rev, 2011, 9:CD004282.
13 Dickinson R, Hall S, Sinclair JE, et al.Using technology to deliver cancer follow-up:a systematic review[J].BMC Cancer, 2014, 14(1):311.
14 Hoffman AJ, Brintnall RA, Brown JK, et al.Virtual reality bringing a new reality to postthoracotomy lung cancer patients via a home-based exercise intervention targeting fatigue while undergoing adjuvant treatment[J].Cancer Nurs, 2014, 37(1):23-33.
15 Timmerman JG, Dekker-van Weering MGH, Stuiver MM, et al.Ambulant monitoring and web-accessible home-based exercise program during outpatient follow-up for resected lung cancer survivors:actual use and feasibility in clinical practice[J].J Cancer Surviv, 2017, 11(6):720-731.
16 Denis F, Viger L, Charron A et al.Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application:pilot study of the sentinel follow-up[J].Support Care Cancer, 2014, 22(6):1467-1473.

[1]	ZHANG Jiawen,YU Yan,ZHANG Wei,CAO Jingyan,LUO Wen,SHANG Lihua. Serum metabolomics of small cell lung cancer patients based on UPLC-TOF/MS [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 200-205.
[2]	LIU Zhiqiang,CHU Yanjie,LIU Jing,WANG Yanbo. Atractylenolide I regulates proliferation and invasion of lung cancer A549 cells through the TLR4/MyD88 pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 228-232.
[3]	ZHANG Yanqiu,HAN Ameng,LI Jinwang,GU Tao,FU Zhanzhao,MAO Yu,ZHANG Zijian,YANG Zhen. The preliminary study on clinical application of CRT+ARC technique in patients with locally advanced lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 256-260.
[4]	ZHAO Su, ZHENG Xiaoyu, ZHU Kaibin, BU Jianlong, XU Shidong. Effect of complete lung cancer resection on the balance of Th17/Treg in the peripheral blood of patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 142-148.
[5]	HU Zhihui, ZHANG Jing. Research progress in the prediction of SNP on radiation-induced lung injury [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 87-91.
[6]	LI Wanzhen, YIN Jun, LI Ping, LIN Xiaohui, ZHANG Guoqian, ZHANG Shuxu. The expression and role of miR-17 in radioresistant cells of non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 391-397.
[7]	CAI Jing, HOU Yue. The expression and clinical significance of serum miR-195 in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 415-419.
[8]	ZHONG Xuelai, YANG Haili, WANG Guonian. Effects of different anesthesia methods on postoperative cognitive function in elderly patients with lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 432-436.
[9]	ZHU Xiaoyun, ZHANG Yaning, LIN Fei, MA Biping. Analysis of lung cancer incidence and mortality in Jinshan District of Shanghai from 2002 to 2013 [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 437-441.
[10]	CUI Xiaoyan,TU Qing,GAN Jianhui. Comparison between nalbuphine and oxycodone applied for patient controlled analgesia on postoperative immunological factor levels in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 309-314.
[11]	WEI Jing,TAO Yuanmeihui,FU Yingmei,ZHAO Jizi,ZHANG Wenli,ZHANG Fengmin. Research progress in the interaction between pulmonary tuberculosis and lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 340-343.
[12]	LEI Junhua, XU Guanhua, ZENG Jiangzheng, HUANG Fen, HE Zhihui, LU Yanda. Research on JAK3/STAT3 mechanism of non-small cell lung cancer NCI-H1975 cells treated with cryptotanshinone combined with cisplatin [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 198-202.
[13]	WAN Jingxuan, LI Honghong, ZHOU Xiangxiang, Ma Lin. Analysis for risk factors of pulmonary thromboembolism in the stage Ⅳ of lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 214-244.
[14]	ZHAI Keke, GAO Yuanyuan, FENG Xiao, XU Jingwen, GONG Yufang, MENG Qingwei. Analysis of first-line NSCLC chemotherapy in the phase Ⅳ patients with distant metastasis and first diagnosis after postoperative adjuvant chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 107-111.
[15]	DU Yesheng, HU Songliu, XU Xiangying. Study of oligodendrocyte metastasis in non-small cell lung cancer by stereotactic radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 154-158.

The application and prospect of telemedicine in lung cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments